To test if recombinant LRIG1 ectodomains (sLRIG1) could suppress melanoma cell proliferation, we exposed a panel of melanoma cell lines with variable LRIG1 expression (Fig. 6A) to sLRIG1 but detected no significant effects on proliferation (Fig. 6B). Here, LRIG1 is linked to melanoma.